Results 161 to 170 of about 19,885,181 (308)

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

open access: yesMolecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober   +16 more
wiley   +1 more source

Designing for Our Future Selves: A Case Study in Age-Inclusive Design Education Through a Reflective Workshop

open access: yesTransformative Social Impact
As the global population ages, the design field faces an urgent imperative to confront ageism and foster more inclusive practices. Yet age-inclusive design remains underrepresented in both education and professional settings—often treated as a niche ...
Kimberly Mitchell
doaj   +1 more source

La cartografía como medio investigativo y pedagógico

open access: yesDearq, 2011
Reconocer que la construcción del conocimiento es esencialmente un producto social basado en las relaciones, convivencia e intercambio con los otros, fue el principio para involucrar a los estudiantes de pregrado del curso del ciclo básico Uniandino ...
Henry Osorio Campillo   +1 more
doaj  

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

open access: yesMolecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi   +14 more
wiley   +1 more source

Integrating Imagination and Design Thinking: Pedagogical Approaches for Postgraduate Creativity

open access: yesInternational Journal of Arts Architecture & Design
Examining the function and possible effects of the "Imaginative Design Thinking" courses created for postgraduate Master of Design (M.Des) students, this paper places its inception within the changing context of higher education.
Rahat Varma
doaj   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy